Category Industry Updates

ADDING

ADDING MULTIMEDIA: Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer

ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective…

Read MoreADDING MULTIMEDIA: Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer
Booz Allen

Booz Allen Hamilton advances orbital warfare capabilities for the space domain

Booz Allen Advances Orbital Warfare for Space Domain Booz Allen Hamilton announced that its corporate venture capital arm, Booz Allen Ventures, has invested in Portal Space Systems, a U.S.-based space technology company developing rapidly maneuverable spacecraft for next-generation orbital operations. Portal Space Systems…

Read MoreBooz Allen Hamilton advances orbital warfare capabilities for the space domain
Cloud Range

Cloud Range won Gold in the 2026 Cybersecurity Excellence Awards for cyber readiness and validation

Cloud Range Wins Gold in 2026 Cybersecurity Excellence Awards for Cyber Readiness and Validation Cloud Range, the industry-leading cyber readiness and simulation platform, has been named a Gold Award recipient in the Cyber Readiness and Validation category of the 2026…

Read MoreCloud Range won Gold in the 2026 Cybersecurity Excellence Awards for cyber readiness and validation
Takeda’s

Takeda’s Zasocitinib showed fast, lasting skin clearance in a once-daily psoriasis pill

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care Takeda announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2…

Read MoreTakeda’s Zasocitinib showed fast, lasting skin clearance in a once-daily psoriasis pill
Alpha

Alpha Cognition reports fiscal 2025 results and operational update

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update Alpha Cognition Inc. a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025,…

Read MoreAlpha Cognition reports fiscal 2025 results and operational update
Healthcare

Healthcare Digital wins 2026 AI Excellence Award for Nutrition AI with Morrison Healthcare.

Healthcare Digital Wins 2026 Artificial Intelligence Excellence Award for Nutrition AI, Developed in Collaboration with Morrison Healthcare Healthcare Digital, the healthcare and senior living division of Compass Digital and the technology arm for Compass Healthcare, today announced it has been named a winner…

Read MoreHealthcare Digital wins 2026 AI Excellence Award for Nutrition AI with Morrison Healthcare.
Arrowhead

Element Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies

Element Science Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Element Science, a pioneering health technology company that has developed the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) to monitor and protect high-risk cardiovascular patients from sudden…

Read MoreElement Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies
iXCells

iXCells joins global effort to study chemo toxicity in human organoids.

iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids partnership with Rosebud1 and funded by Incite, the project will initially focus on predicting toxicity in heart, liver, and kidney tissue models, to develop personalized, multi-organ toxicity profiles for…

Read MoreiXCells joins global effort to study chemo toxicity in human organoids.
Sinopia Biosciences

Sinopia Biosciences wins NCI grant to advance LEADS® oncology platform.

Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced it has been awarded a…

Read MoreSinopia Biosciences wins NCI grant to advance LEADS® oncology platform.